Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 115

1.

Prediction of adverse maternal outcomes in pre-eclampsia: development and validation of the fullPIERS model.

von Dadelszen P, Payne B, Li J, Ansermino JM, Broughton Pipkin F, Côté AM, Douglas MJ, Gruslin A, Hutcheon JA, Joseph KS, Kyle PM, Lee T, Loughna P, Menzies JM, Merialdi M, Millman AL, Moore MP, Moutquin JM, Ouellet AB, Smith GN, Walker JJ, Walley KR, Walters BN, Widmer M, Lee SK, Russell JA, Magee LA; PIERS Study Group..

Lancet. 2011 Jan 15;377(9761):219-27. doi: 10.1016/S0140-6736(10)61351-7.

PMID:
21185591
2.

Predicting complications in pre-eclampsia: external validation of the fullPIERS model using the PETRA trial dataset.

Akkermans J, Payne B, von Dadelszen P, Groen H, Vries Jd, Magee LA, Mol BW, Ganzevoort W.

Eur J Obstet Gynecol Reprod Biol. 2014 Aug;179:58-62. doi: 10.1016/j.ejogrb.2014.05.021.

PMID:
24965981
3.

A risk prediction model for the assessment and triage of women with hypertensive disorders of pregnancy in low-resourced settings: the miniPIERS (Pre-eclampsia Integrated Estimate of RiSk) multi-country prospective cohort study.

Payne BA, Hutcheon JA, Ansermino JM, Hall DR, Bhutta ZA, Bhutta SZ, Biryabarema C, Grobman WA, Groen H, Haniff F, Li J, Magee LA, Merialdi M, Nakimuli A, Qu Z, Sikandar R, Sass N, Sawchuck D, Steyn DW, Widmer M, Zhou J, von Dadelszen P; miniPIERS Study Working Group..

PLoS Med. 2014 Jan;11(1):e1001589. doi: 10.1371/journal.pmed.1001589.

4.

Performance of the fullPIERS model in predicting adverse maternal outcomes in pre-eclampsia using patient data from the PIERS (Pre-eclampsia Integrated Estimate of RiSk) cohort, collected on admission.

Payne B, Hodgson S, Hutcheon JA, Joseph KS, Li J, Lee T, Magee LA, Qu Z, von Dadelszen P; PIERS Study Group..

BJOG. 2013 Jan;120(1):113-8. doi: 10.1111/j.1471-0528.2012.03496.x.

5.

Proteinuria in pre-eclampsia: how much matters?

Chan P, Brown M, Simpson JM, Davis G.

BJOG. 2005 Mar;112(3):280-5.

6.

Abnormal liver function tests as predictors of adverse maternal outcomes in women with preeclampsia.

Kozic JR, Benton SJ, Hutcheon JA, Payne BA, Magee LA, von Dadelszen P; Preeclampsia Integrated Estimate of RiSk Study Group..

J Obstet Gynaecol Can. 2011 Oct;33(10):995-1004.

PMID:
22014776
7.

The prediction of adverse maternal outcomes in preeclampsia.

von Dadelszen P, Magee LA, Devarakonda RM, Hamilton T, Ainsworth LM, Yin R, Norena M, Walley KR, Gruslin A, Moutquin JM, Lee SK, Russell JA.

J Obstet Gynaecol Can. 2004 Oct;26(10):871-9. English, French.

PMID:
15507197
8.

Moving beyond essential interventions for reduction of maternal mortality (the WHO Multicountry Survey on Maternal and Newborn Health): a cross-sectional study.

Souza JP, Gülmezoglu AM, Vogel J, Carroli G, Lumbiganon P, Qureshi Z, Costa MJ, Fawole B, Mugerwa Y, Nafiou I, Neves I, Wolomby-Molondo JJ, Bang HT, Cheang K, Chuyun K, Jayaratne K, Jayathilaka CA, Mazhar SB, Mori R, Mustafa ML, Pathak LR, Perera D, Rathavy T, Recidoro Z, Roy M, Ruyan P, Shrestha N, Taneepanichsku S, Tien NV, Ganchimeg T, Wehbe M, Yadamsuren B, Yan W, Yunis K, Bataglia V, Cecatti JG, Hernandez-Prado B, Nardin JM, Narváez A, Ortiz-Panozo E, Pérez-Cuevas R, Valladares E, Zavaleta N, Armson A, Crowther C, Hogue C, Lindmark G, Mittal S, Pattinson R, Stanton ME, Campodonico L, Cuesta C, Giordano D, Intarut N, Laopaiboon M, Bahl R, Martines J, Mathai M, Merialdi M, Say L.

Lancet. 2013 May 18;381(9879):1747-55. doi: 10.1016/S0140-6736(13)60686-8.

PMID:
23683641
9.

Pre-eclampsia, eclampsia and adverse maternal and perinatal outcomes: a secondary analysis of the World Health Organization Multicountry Survey on Maternal and Newborn Health.

Abalos E, Cuesta C, Carroli G, Qureshi Z, Widmer M, Vogel JP, Souza JP; WHO Multicountry Survey on Maternal and Newborn Health Research Network..

BJOG. 2014 Mar;121 Suppl 1:14-24. doi: 10.1111/1471-0528.12629.

10.

Oxygen saturation as a predictor of adverse maternal outcomes in women with preeclampsia.

Millman AL, Payne B, Qu Z, Douglas MJ, Hutcheon JA, Lee T, Magee LA, Walley KR, von Dadelszen P.

J Obstet Gynaecol Can. 2011 Jul;33(7):705-14.

PMID:
21749746
11.

Using clinical symptoms to predict adverse maternal and perinatal outcomes in women with preeclampsia: data from the PIERS (Pre-eclampsia Integrated Estimate of RiSk) study.

Yen TW, Payne B, Qu Z, Hutcheon JA, Lee T, Magee LA, Walters BN, von Dadelszen P.

J Obstet Gynaecol Can. 2011 Aug;33(8):803-9.

PMID:
21846435
12.

Evaluation of a definition of pre-eclampsia.

North RA, Taylor RS, Schellenberg JC.

Br J Obstet Gynaecol. 1999 Aug;106(8):767-73.

PMID:
10453825
13.

Plasma uric acid remains a marker of poor outcome in hypertensive pregnancy: a retrospective cohort study.

Hawkins TL, Roberts JM, Mangos GJ, Davis GK, Roberts LM, Brown MA.

BJOG. 2012 Mar;119(4):484-92. doi: 10.1111/j.1471-0528.2011.03232.x.

14.

Clinical risk prediction for pre-eclampsia in nulliparous women: development of model in international prospective cohort.

North RA, McCowan LM, Dekker GA, Poston L, Chan EH, Stewart AW, Black MA, Taylor RS, Walker JJ, Baker PN, Kenny LC.

BMJ. 2011 Apr 7;342:d1875. doi: 10.1136/bmj.d1875.

15.

External Validation of the fullPIERS Model for Predicting Adverse Maternal Outcomes in Pregnancy Hypertension in Low- and Middle-Income Countries.

Ukah UV, Payne B, Lee T, Magee LA, von Dadelszen P.

Hypertension. 2017 Feb 6. pii: HYPERTENSIONAHA.116.08706. doi: 10.1161/HYPERTENSIONAHA.116.08706. [Epub ahead of print]

PMID:
28167685
16.

Prediction of postpartum hemorrhage in women with gestational hypertension or mild preeclampsia at term.

Koopmans CM, van der Tuuk K, Groen H, Doornbos JP, de Graaf IM, van der Salm PC, Porath MM, Kuppens SM, Wijnen EJ, Aardenburg R, van Loon AJ, Akerboom BM, van der Lans PJ, Mol BW, van Pampus MG; HYPITAT study group..

Acta Obstet Gynecol Scand. 2014 Apr;93(4):399-407. doi: 10.1111/aogs.12352.

PMID:
24575790
17.

Characteristics of preeclampsia- and eclampsia-related maternal death in rural Haiti.

Small MJ, Kershaw T, Frederic R, Blanc C, Neale D, Copel J, Williams KP.

J Matern Fetal Neonatal Med. 2005 Nov;18(5):343-8.

PMID:
16390796
18.

PIERS proteinuria: relationship with adverse maternal and perinatal outcome.

Payne B, Magee LA, Côté AM, Hutcheon JA, Li J, Kyle PM, Menzies JM, Moore MP, Parker C, Pullar B, von Dadelszen P, Walters BN.

J Obstet Gynaecol Can. 2011 Jun;33(6):588-97.

PMID:
21846448
19.

Induction of labour versus expectant monitoring for gestational hypertension or mild pre-eclampsia between 34 and 37 weeks' gestation (HYPITAT-II): a multicentre, open-label randomised controlled trial.

Langenveld J, Broekhuijsen K, van Baaren GJ, van Pampus MG, van Kaam AH, Groen H, Porath M, Oudijk MA, Bloemenkamp KW, Groot CJ, van Beek E, van Huizen ME, Oosterbaan HP, Willekes C, Wijnen-Duvekot EJ, Franssen MT, Perquin DA, Sporken JM, Woiski MD, Bremer HA, Papatsonis DN, Brons JT, Kaplan M, Nij Bijvanck BW, Mol BW; HYPITAT-II study group..

BMC Pregnancy Childbirth. 2011 Jul 7;11:50. doi: 10.1186/1471-2393-11-50.

20.

Risk indicators for eclampsia in gestational hypertension or mild preeclampsia at term.

Koopmans CM, Zwart JJ, Groen H, Bloemenkamp KW, Mol BW, Van Pampus MG, Van Roosmalen J.

Hypertens Pregnancy. 2011;30(4):433-46. doi: 10.3109/10641955.2010.506236.

PMID:
20822426
Items per page

Supplemental Content

Support Center